Vasculitis Trial, Recruiting NCT05565885 Sponsor: University Hospital, Tours Condition: Vasculitis
Back to Vasculitis

Vasculitis Trial, Recruiting

NCT05565885
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are older than 16 years of age
  • You have active vasculitis (inflammation of the blood vessels) that is either newly diagnosed or has come back after a period of improvement
  • You have been diagnosed with IgA vasculitis (a type of blood vessel inflammation linked to a protein called IgA)
  • You have been diagnosed with ANCA vasculitis (a type of blood vessel inflammation linked to certain antibodies in the blood)
  • You have been diagnosed with Giant cell arteritis (a type of inflammation affecting larger blood vessels, often in the head)

Who may not be able to join:

  • You have asked for your personal data not to be used or processed
  • You are currently pregnant
  • You have tested positive for HIV, Hepatitis B (HBV), or Hepatitis C (HCV)
  • You have been treated with steroids, drugs that suppress the immune system, or biological therapies in the past month
  • You are unable to read or understand the information leaflet provided about the trial
  • You are an adult who is under legal guardianship or supervised protection (confirm with trial site)

⚠️ Important: Always verify eligibility with the trial site directly before applying. This information is provided to help you understand the trial criteria only and is not medical advice. A healthcare professional or the trial team must assess whether this trial is right for you.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 02 47 47 37 15

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
University Hospital, Tours
Registry
ClinicalTrials.gov
Start date
22 November 2022
Est. completion
1 December 2037

Where this trial is recruiting

🇫🇷 France

Primary endpoints

cytokine/chemokine/metabolite concentrations; cytokine/chemokine/metabolite concentrations; cytokine/chemokine/metabolite concentrations; cytokine/chemokine/metabolite concentrations; cytokine/chemokine/metabolite concentrations; percentage of different non-conventional T cell populations; percentage of different non-conventional T cell populations; percentage of different non-conventional T cell populations; percentage of different non-conventional T cell populations; percentage of different non-conventional T cell populations

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov